Context

Since fluoxetine's release in the late 1980s, the use of antidepressants has increased steadily. Women of childbearing age make-up a significant proportion of users, so exposure during pregnancy is common. This is particularly true for early pregnancy exposure which often occurs before the woman knows she is pregnant. Estimates are that up to 13% of pregnancies will be exposed.1 The impact of these drugs on pregnancy outcomes has been a growing area of concern and debate.2 A major concern is whether the drugs are associated with congenital malformations. In their systematic review and …